XXIABEL

Serial Number 98401895
731

Registration Progress

Application Filed
Feb 12, 2024
Under Examination
Nov 26, 2024
Approved for Publication
Oct 15, 2024
Published for Opposition
Oct 15, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: May 26, 2026 211 days

Trademark Image

XXIABEL

Basic Information

Serial Number
98401895
Filing Date
February 12, 2024
Published for Opposition
October 15, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Oct 1, 2025
Application
Pending
Classes
005

Rights Holder

Anthos Therapeutics, Inc.

03
Address
101 Main Street, Suite 1210
Cambridge, MA 02142

Ownership History

Anthos Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Anthos Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

Next Deadline
211 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
May 26, 2026
Extension Available
Until November 26, 2025

Application History

16 events
Date Code Type Description Documents
Oct 2, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 1, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 1, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 1, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 11, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 10, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 10, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 10, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 26, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 15, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 15, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 25, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 8, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 5, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 11, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 12, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and associated disorders; pharmaceutical preparations for the treatment of cancer-associated diseases and disorders

Classification

International Classes
005